Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic.
Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in Malawi.
Strong epistatic interactions within a single protein.
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure.
An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study.
Patterns of transmitted HIV drug resistance in Europe vary by risk group.
Decreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivity.
Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study.
2014 Update of the drug resistance mutations in HIV-1.